One intravitreal injection of the dexamethasone implant in patients with refractory DME induced significant anatomic and functional improvements, but these improvements only lasted for short periods ...

Formosa Pharmaceuticals and Cipla Limited have entered into an exclusive licensing agreement for the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007) for ...

Rebecca Silverman, MD, and associates advised evaluating the cerebrospinal fluid (CSF) in patients suspected of having vitreoretinal lymphoma to ensure that vitreoretinal lymphoma is not missed. 1 She ...

This treatment is already approved for both diabetic macular edema (DME) and NIU-PS outside the US, including in 17 European countries. The US Food and Drug Administration (FDA) has approved an ...

The closing of the merger is expected to occur as soon as practicable, subject to the satisfaction or waiver of the remaining customary closing conditions. Kalaris Therapeutics, Inc. and AlloVir, ...

Among the promising areas of retinal disease research are innovative approaches targeting pan-vascular endothelial growth factor inhibition. The treatment landscape for retinal diseases is advancing ...

UBX1325 is a novel BCL-xL inhibitor designed to eliminate senescent cells in diabetic retinal blood vessels, while leaving healthy ones intact. After review by the Data and Safety Monitoring Board, ...

The data was included in the paper, titled “Sozinibercept Combination Therapy for Neovascular Age-Related Macular Degeneration: Phase 2b Study Subgroup Analysis by Lesion Type.” Data from Opthea ...

Miguel A. Quiroz-Reyes, MD, PhD, and colleagues found that cigarette smoking negatively affects the choroidal vascularity, as indicated by a significant reduction of the choroidal vascularity index ...

A total of 43 patients who recovered from the SARS-CoV-2 infection with mild pneumonia were included along with 45 healthy individuals. Researchers from Istanbul, Turkey, conducted a study that found ...

Physicians’ Education Resource (PER) has launched Retina Resource, a comprehensive source of education and information on the latest innovations in anti-VEGF therapy, tailored to retina specialists ...

Investigators published a recent case report 1 that described the development of bilateral retinal detachments in a teenager. The patient was an otherwise healthy 19-year-old man who had been referred ...